GE HealthCare — Third Quarter 2026 Earnings Summary

GE HealthCare reported third-quarter 2026 total revenues of $5.5 billion, representing a 7.2% year-over-year increase with organic growth of 6.2%. The company achieved a net income margin of 11.1% and reported diluted earnings per share of $1.36, a 39.1% increase from the prior year. Driven by strong performance across all segments, GE HealthCare raised its full-year 2026 guidance to approximately 4.0% organic revenue growth and $4.95 to $5.05 adjusted earnings per share. Additionally, the company announced plans to acquire SOFIE Biosciences for $945 million and increased its quarterly dividend by 14% to $0.04 per share.